Transfusion Trial to Prevent Platelet Alloimmunization

Mc Farland, Janice G.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01HL042832-07
• Application #: 2220708
• Study Section: Clinical Trials Review Committee (CLTR)
• Project Start: 1989-08-01
• Project End: 1997-07-31
• Budget Start: 1995-08-01
• Budget End: 1997-07-31
• Support Year: 7
• Fiscal Year: 1995

Institution

• Name: Bloodcenter of Wisconsin, Inc.
• City: Milwaukee
• State: WI
• Country: United States
• Zip Code: 53233

Publications

Slichter, Sherrill J; Bolgiano, Douglas; Kao, Kuo-Jang et al. (2011) Persistence of lymphocytotoxic antibodies in patients in the trial to reduce alloimmunization to platelets: implications for using modified blood products. Transfus Med Rev 25:102-10

Slichter, Sherrill J; Davis, Kathryn; Enright, Helen et al. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 105:4106-14

Enright, Helen; Davis, Kathryn; Gernsheimer, Terry et al. (2003) Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial. Transfusion 43:1545-52